Share This Page
Drug Price Trends for URO-PAIN
✉ Email this page to a colleague
Average Pharmacy Cost for URO-PAIN
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| URO-PAIN 99.5 MG TABLET | 57237-0330-21 | 0.18222 | EACH | 2025-05-21 |
| URO-PAIN DUAL 162-162.5 MG TAB | 57237-0332-42 | 0.16797 | EACH | 2025-05-21 |
| URO-PAIN 99.5 MG TABLET | 57237-0330-42 | 0.18222 | EACH | 2025-05-21 |
| URO-PAIN 95 MG TABLET | 57237-0331-03 | 0.12696 | EACH | 2025-05-21 |
| URO-PAIN 99.5 MG TABLET | 57237-0330-21 | 0.18261 | EACH | 2025-04-23 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Market Analysis and Price Projections for URO-PAIN
Overview of URO-PAIN
URO-PAIN, also known as phenazopyridine, is a medication used to relieve pain and discomfort associated with urinary tract infections, such as burning sensation while urinating. Here’s a detailed analysis of the market and price projections for URO-PAIN.
Market Context: Pain Management Drugs
The global pain management drugs market is experiencing significant growth, driven by increasing chronic diseases, a rising geriatric population, and favorable regulatory scenarios. Here are some key points:
- Global Market Size: The global pain management drugs market was valued at USD 81.15 billion in 2023 and is projected to reach USD 120.16 billion by 2033, growing at a CAGR of 4% during the forecast period[1].
- Regional Growth: North America dominates the market, accounting for more than 44.80% of the revenue share in 2023, due to a large number of patients with chronic disorders and advanced healthcare infrastructure[1].
URO-PAIN Market Segment
Drug Class and Indication
URO-PAIN falls under the category of analgesics and is specifically used for urinary tract pain.
- Drug Class: While URO-PAIN is not a major segment in the broader pain management market, it is part of the analgesics category, which includes NSAIDs, opioids, and other pain-relieving medications[1][3].
- Indication: The primary indication for URO-PAIN is the relief of pain associated with urinary tract infections, which is a subset of the broader pain management market.
Pricing and Cost Analysis
Current Pricing
As of the latest data, here are the pricing details for URO-PAIN:
- Cost: The cost for URO-PAIN 95 mg oral tablet is around $19 for a supply of 30 tablets, depending on the pharmacy. A generic version is available at a lower price, starting from $13.15 for 30 tablets[2].
Price Projections
While specific price projections for URO-PAIN are not available, we can infer from broader market trends:
- Pharmacy Price Increases: Hospital and non-acute care facility pharmacy prices are expected to rise by 3.78% from July 2023 to July 2024, reflecting increases in both prices and utilization. This trend could influence the pricing of all pharmaceuticals, including URO-PAIN[5].
- Generic Competition: The availability of generic versions of URO-PAIN is likely to keep prices competitive. Generic drugs typically offer significant cost savings, which can stabilize or reduce the overall cost of the medication[2].
Distribution Channels
Retail and Online Pharmacies
- Distribution: The global pain management drugs market, including URO-PAIN, is segmented into online pharmacies, retail pharmacies, and hospital pharmacies. Retail pharmacies dominated the distribution channel segment in 2023 due to high demand[1].
- Accessibility: The widespread availability of URO-PAIN through various distribution channels, including online pharmacies and retail pharmacies, ensures easy access for patients.
Market Drivers and Challenges
Drivers
- Increasing Chronic Diseases: The rise in chronic diseases, such as urinary tract infections, drives the demand for pain management drugs like URO-PAIN[1][3].
- Geriatric Population: An aging population is more prone to various types of pain, including urinary tract pain, which increases the demand for URO-PAIN[3].
Challenges
- Regulatory Environment: Changes in regulatory policies can affect the pricing and availability of URO-PAIN. However, the current favorable regulatory scenario supports the growth of pain management drugs[3].
- Generic Competition: The presence of generic versions can reduce the market share of branded URO-PAIN, affecting its pricing and revenue[2].
Key Takeaways
- Market Growth: The pain management drugs market, including URO-PAIN, is expected to grow significantly due to increasing chronic diseases and a rising geriatric population.
- Pricing Stability: The availability of generic versions and competitive pricing strategies are likely to keep the cost of URO-PAIN stable or reduce it.
- Distribution Channels: Retail pharmacies and online pharmacies play a crucial role in the distribution of URO-PAIN, ensuring easy access for patients.
FAQs
What is URO-PAIN used for?
URO-PAIN, or phenazopyridine, is used to relieve pain and discomfort associated with urinary tract infections.
How much does URO-PAIN cost?
The cost for URO-PAIN 95 mg oral tablet is around $19 for a supply of 30 tablets, with generic versions available starting from $13.15 for 30 tablets.
What are the key drivers of the pain management drugs market?
The key drivers include the increasing incidence of chronic diseases, a rising geriatric population, and favorable regulatory scenarios.
How does the availability of generic versions affect URO-PAIN pricing?
The availability of generic versions of URO-PAIN can reduce its market share and pricing, offering significant cost savings to patients.
What is the projected growth rate of the global pain management drugs market?
The global pain management drugs market is projected to grow at a CAGR of 4% from 2024 to 2033.
Sources
- Precedence Research, "Pain Management Drugs Market Size To Hit USD 120.16 Bn By 2033," August 2024.
- Drugs.com, "Uro-Pain Prices, Coupons, Copay Cards & Patient Assistance."
- Global Market Insights, "Pain Management Drugs Market Share, Trends & Forecast, 2032."
- BioSpace, "U.S. Pain Management Drugs Market Size and Growth, Statistics 2024 to 2033."
- Managed Healthcare Executive, "Hospital Drug Spending to Increase through July 2024."
More… ↓
